生物
体细胞突变
基因
T细胞白血病
生发中心
成人T细胞白血病/淋巴瘤
淋巴瘤
白血病
基因组
遗传学
癌症研究
克拉斯
突变
B细胞
抗体
免疫学
作者
Yasunori Kogure,Takuro Kameda,Junji Koya,Makoto Yoshimitsu,Kisato Nosaka,Jun‐ichirou Yasunaga,Yoshitaka Imaizumi,Mizuki Watanabe,Yuki Saito,Yuta Ito,Marni B. McClure,Mariko Tabata,Sumito Shingaki,Kota Yoshifuji,Kenichi Chiba,Ai Okada,Nobuyuki Kakiuchi,Yasuhito Nannya,Ayako Kamiunten,Yuki Tahira
出处
期刊:Blood
[Elsevier BV]
日期:2021-10-25
卷期号:139 (7): 967-982
被引量:93
标识
DOI:10.1182/blood.2021013568
摘要
Adult T-cell leukemia/lymphoma (ATL) is an aggressive neoplasm immunophenotypically resembling regulatory T cells, associated with human T-cell leukemia virus type-1. Here, we performed whole-genome sequencing (WGS) of 150 ATL cases to reveal the overarching landscape of genetic alterations in ATL. We discovered frequent (33%) loss-of-function alterations preferentially targeting the CIC long isoform, which were overlooked by previous exome-centric studies of various cancer types. Long but not short isoform-specific inactivation of Cic selectively increased CD4+CD25+Foxp3+ T cells in vivo. We also found recurrent (13%) 3'-truncations of REL, which induce transcriptional upregulation and generate gain-of-function proteins. More importantly, REL truncations are also common in diffuse large B-cell lymphoma, especially in germinal center B-cell-like subtype (12%). In the non-coding genome, we identified recurrent mutations in regulatory elements, particularly splice sites, of several driver genes. In addition, we characterized the different mutational processes operative in clustered hypermutation sites within and outside immunoglobulin/T-cell receptor genes and identified the mutational enrichment at the binding sites of host and viral transcription factors, suggesting their activities in ATL. By combining the analyses for coding and noncoding mutations, structural variations, and copy number alterations, we discovered 56 recurrently altered driver genes, including 11 novel ones. Finally, ATL cases were classified into 2 molecular groups with distinct clinical and genetic characteristics based on the driver alteration profile. Our findings not only help to improve diagnostic and therapeutic strategies in ATL, but also provide insights into T-cell biology and have implications for genome-wide cancer driver discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI